Podium 01
台灣前列腺癌病人可接受根除性前列腺全切除手術以餘命估算-2023年趨勢
盧致誠1.2 范文宙1 鄭哲舟1
奇美醫療財團法人柳營奇美醫院 外科部 泌尿外科
TREND OF LIFE EXPECTANCY as references for RADICAL PROSTATECTOMY OF PROSTATE CANCER IN TAIWAN—2023 UPDATE
Chih-Cheng Lu1.2, Wen-Chou Fan1, Tse-Chou Cheng1
1Division of Urology, Department of Surgery, Chi Mei Medical Center, Liouying, Tainan
2Department of Information Management, National Chung Cheng University, Chiayi
Purpose:
This study is to review the trend of life expectancy of male population in Taiwan region for the reference in clinical practice.
Materials and Methods:
Up to October 2023, life expectancy reports by the service of the Department of Statistics, Ministry of the Interior (MOI) of Taiwan were reviewed up to 2021. The printed practice guidelines for prostate cancer by Taiwan Cooperation Oncology Group TCOG and National Comprehensive Cancer Network (NCCN) were reviewed. Investigate the trend of life expectancy of the male population in Taiwan region which includes Taipei city, Kaohsiung city but no Fukien special areas. Although 10 years of life expectancy was considered by TOCG, life expectancy of the patients receiving radical prostatectomy in high risk group of symptomatic localized prostate cancer is 5 years or more, based on NCCN 2023,
Results:
From 1991 to 2016 life table by Taiwanese MOI were available. Average 5-year survival rate of prostate cancer is around 77% mentioned by TCOG. From 1991 to 2012, the male life expectancy at birth in Taiwan was from 71.8 up to 76.4 years. The report of life expectancy more than 10 years from MOI showed at the age of 71 years in 1991, 72 years from 1992 to 1995, 74 years in 1996, 75 years from 1997 to 1999, 76 years from 2001 to 2005, 77 years in 2006 to 2007. In 2012, the male life expectancy at the age of 77 and 78 years were 10.13 and 9.62 years, respectively. In 2013, the male life expectancy at the age of 77 and 78 years were 10.41 and 9.88 years, In 2016, the male life expectancy at the age of 76, 77 and 78 years were10.27, 9.72 and 9.18 years, In 2019, the male life expectancy at the age of 76, 77, 78 and 79 years were11.17, 10.58, 10.00 and 9.44 years. In 2021, the life expectancy of 84, and 85 years were 6.5 and 6.0 years, which imply the age is a less important factor for radical surgery in prostate cancer.
Conclusion:
In this timely updating study, the possible upper limit is even at the age of 85 years for the patients with high–risk localized prostate cancer considering to undergo radical prostatectomy based on NCCN practice guidelines in Taiwan region. Further research with longer follow-up is needed to clarify the relationship.